Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Matthias Rath has a total of 133 co-authors. Here are the top co-authors by number of shared publications:

  • Ute Felbor

    Department of Human Genetics, University Medicine Greifswald and Interfaculty Institute of Genetics and Functional Genomics, University of Greifswald, Germany

    12 shared publications
  • Konrad Schwefel

    Department of Human Genetics, University Medicine Greifswald and Interfaculty Institute of Genetics and Functional Genomics, University of Greifswald, Greifswald, Germany

    8 shared publications
  • Robin A. Pilz

    Department of Human Genetics, University Medicine Greifswald and Interfaculty Institute of Genetics and Functional Genomics, University of Greifswald, Germany

    7 shared publications
  • Stefanie Spiegler

    Department of Human Genetics, University Medicine Greifswald and Interfaculty Institute of Genetics and Functional Genomics, University of Greifswald, Greifswald, Germany

    6 shared publications
  • Christiane D. Much

    Department of Human Genetics , University Medicine Greifswald , Greifswald , Germany

    5 shared publications
  • Dariush Skowronek

    Department of Human Genetics University Medicine Greifswald, and Interfaculty Institute of Genetics and Functional Genomics, University of Greifswald Greifswald Germany

    5 shared publications

Latest Publications

  • Lifetime Risk of First Symptomatic ICH or Seizure in Familial Cerebral Cavernous Malformations

    by Philipp Dammann, Alejandro N. Santos, Laven Mavarani, Stéphanie Guey, Hugues Chabriat, Dominique Herve, Jacob Croft, Mellisa Renteria, David Jang, Jun Zhang, et al.

    Familial cavernous malformations (FCMs) are vascular lesions that pose a lifelong risk of symptomatic hemorrhage (SH) and seizures, yet their natural history remains unclear. This study aims to determine the cumulative lifetime risk of a first SH and/or seizure and assess whether genetic variations influence these risks. This international, multicenter retrospective cohort study included data from 16 tertiary referral centers and 1 patient advocacy group. Eligible patients had confirmed or suspected FCM, available magnetic resonance imaging (MRI) data, documented baseline clinical features, and longitudinal follow-up (FU). Functional outcomes were assessed using the modified Rankin Scale (mRS) at last FU. Direct adjusted survival curves and mixed-effects Cox regression analyses were performed to estimate cumulative lifetime risk. The association between genetic variations and SH/seizure rates was evaluated, and mixed-effects logistic regression assessed the effect of SH/seizures on mRS outcomes. A total of 1,592 patients with FCM were included, with a mean age of 37.6 years (SD 17.1) and 55.7% female. The median FU was 42 years (IQR: 27-55), totaling 64,146 person-years. Of these, 869 (54.6%) had confirmed FCM, 775 (48.7%) experienced at least 1 hemorrhage, and 447 (28.1%) had at least 1 seizure. Genetic testing was performed in 47.7%, identifying CCM1 (31.0%), CCM2 (4.8%), and CCM3 (1.9%) variations. The lifetime risk of a first SH was ∼80%, with an event rate that remained constant beyond age 20. The lifetime risk of a first seizure was ∼45%. Patients with CCM3 variations exhibited a more aggressive hemorrhagic course than those with CCM1 (hazard ratio 1.799, 95% CI 1.008-3.208). SH and seizures were independently associated with worse mRS outcomes at last FU. The event rate of SH and seizures remained stable over time, leading to high cumulative lifetime risks. Patients with CCM3 variations exhibited a more aggressive disease course. Limitations include the non-population-based design, selection bias from tertiary centers, retrospective data collection, and variability in data extraction across centers. However, this study represents the largest international FCM cohort to date, improving the precision of risk estimates and providing valuable insights into disease progression.


  • Open Access

    Oxford Nanopore long-read sequencing with CRISPR/Cas9-mediated target selection for accurate characterization of copy number variants in the LDLR gene

    by Robin A. Pilz, Dariush Skowronek, Loisa D. Bonde, Tadeusz Kałużewski, Ole J. Schamuhn, Raila Busch, Agnieszka Gach, Matthias Rath, Elisabeth Steinhagen-Thiessen, Ute Felbor


  • Open Access

    Novel postzygotic RASA1 mutation in a patient with Parkes Weber syndrome: A case report and literature review

    by Robin A. Pilz, Dariush Skowronek, Tamara Ehresmann, Ute Felbor, Matthias Rath

    Key Clinical Message: Not only germline but also postzygotic mutations in the RASA1 or EPHB4 genes can lead to capillary malformation‐arteriovenous malformation (CM‐AVM) syndrome. As it is not always possible to clinically distinguish between constitutional variants and postzygotic mosaicism, a sufficiently high sequencing depth must be used in genetic diagnostics to detect both. Capillary malformation‐arteriovenous malformation (CM‐AVM) syndrome, with or without Parkes Weber syndrome, is a rare autosomal dominant disease caused by pathogenic RASA1 or EPHB4 variants. Up to 80% of CM‐AVM cases have an affected parent. Gene panel sequencing was performed for a 4‐year‐old girl with multiple CMs, two capillary stains on the left leg, and associated overgrowth of the second toe. We also reviewed published cases with mosaic RASA1 and EPHB4 mutations. A mosaic RASA1 loss‐of‐function mutation was detected with a variant allele frequency (VAF) of 20% in the blood and oral epithelial cells of the index patient. The literature review illustrates that the severity of the clinical phenotype does not correlate with the VAF. We also identified a germline nonsense variant in the patient's TEK gene. However, inactivating TEK variants do not cause a vascular phenotype but can confer an increased risk for primary congenital glaucoma with variable expressivity. The case presented here illustrates that the choice of the sequencing depth of a diagnostic next‐generation sequencing test for CM‐AVM patients should always take mosaicism into account and that a good knowledge of the sequenced genes and associated disease mechanisms is necessary for adequate genetic counseling.


  • A novel, homozygous mutation in GFI1B causing inherited thrombocytopenia with Glanzmann-like platelet dysfunction

    by C Zaninetti, K Selleng, T Thiele, J Wesche, M Rath, U Felbor, A Greinacher

    Introduction Inherited platelet disorders (IPD) are rare. To date mutations in around 80 genes have been identified as causes of IPD with heterogeneous clinical manifestations [1] [2]. Recognizing IPD can be difficult but is advisable in order to provide patients with proper counseling and treatment in bleeding situations [3]. Novel mutations are frequently found and require an accurate platelet diagnostic work-up to confirm their clinical relevance and pathogenic role [4]. We report a female patient with lifelong hemorrhagic diathesis. Method Clinical assessment, platelet phenotyping by flow-cytometry, immunofluorescence microscopy, standard aggregometry, DNA analysis as well as a platelet reactive antibody screening using MAIPA were performed. Results The patient was a 46-year-old woman with congenital, moderate thrombocytopenia (range 55-76,000/µl) and substantial spontaneous and provoked bleeding symptoms. A diagnosis of Glanzmann Thrombasthenia (GT) had been previously made at another institution, and the patient was consequently treated on-demand with platelet concentrates. Family history strongly suggested an autosomal-dominant inherited bleeding disorder. By standard aggregometry, a GT-like platelet dysfunction (absence of platelet aggregation after stimulation with all agonists except ristocetin at high concentration) was found. However, the expression of platelet glycoprotein receptor GPIIbIIIa and GPIbIX was normal. No platelet autoantibodies potentially causing acquired GT were detected. By light-microscopy, we found partially degranulated large platelets and rarely giant platelets. A mild alpha-storage pool disorder was detected by immunofluorescence-microscopy as well as expression of the stem cell antigen CD34 on platelet surfaces. The combination of autosomal-dominant macro-thrombocytopenia with reduced alpha granule markers and expression of CD34 strongly indicated a mutation in GFI1B gene [5]. Genetic testing confirmed a hitherto non-reported GFI1B variant, p.His181Leu, which was present in a homozygous state. Alternative splicing results in two GFI1B isoforms. The identified missense variant was predicted to affect the function of the longer isoform, which is required for megakaryopoiesis and platelet production but not of the short one which is essential for erythroid differentiation. Because of the highly consistent platelet phenotype, we interpreted this variant as pathogenic. In addition, we suggest that the particular homozygous state of the mutation can lead to the GT-like platelet dysfunction, which is unusual in patients with GFI1B-related thrombocytopenia. No mutations were present in ITGA2B and ITGB3. Conclusion In patients presenting with platelet dysfunction immunofluorescence on the blood smear allows extended platelet phenotyping. This can guide further diagnostic steps and, together with genetic testing, result in a final diagnosis Article published online: 20 February 2023 © 2023. Thieme. All rights reserved. Georg Thieme Verlag Rüdigerstraße 14, 70469 Stuttgart, Germany

  • Open Access

    Endothelial Differentiation of CCM1 Knockout iPSCs Triggers the Establishment of a Specific Gene Expression Signature

    by Robin A. Pilz, Dariush Skowronek, Lara Mellinger, Sander Bekeschus, Ute Felbor, Matthias Rath

    Cerebral cavernous malformation (CCM) is a neurovascular disease that can lead to seizures and stroke-like symptoms. The familial form is caused by a heterozygous germline mutation in either the CCM1, CCM2, or CCM3 gene. While the importance of a second-hit mechanism in CCM development is well established, it is still unclear whether it immediately triggers CCM development or whether additional external factors are required. We here used RNA sequencing to study differential gene expression in CCM1 knockout induced pluripotent stem cells (CCM1−/− iPSCs), early mesoderm progenitor cells (eMPCs), and endothelial-like cells (ECs). Notably, CRISPR/Cas9-mediated inactivation of CCM1 led to hardly any gene expression differences in iPSCs and eMPCs. However, after differentiation into ECs, we found the significant deregulation of signaling pathways well known to be involved in CCM pathogenesis. These data suggest that a microenvironment of proangiogenic cytokines and growth factors can trigger the establishment of a characteristic gene expression signature upon CCM1 inactivation. Consequently, CCM1−/− precursor cells may exist that remain silent until entering the endothelial lineage. Collectively, not only downstream consequences of CCM1 ablation but also supporting factors must be addressed in CCM therapy development.


  • Open Access

    Cas9-Mediated Nanopore Sequencing Enables Precise Characterization of Structural Variants in CCM Genes

    by Dariush Skowronek, Robin A. Pilz, Loisa Bonde, Ole J. Schamuhn, Janne L. Feldmann, Sabine Hoffjan, Christiane D. Much, Ute Felbor, Matthias Rath

    Deletions in the CCM1, CCM2, and CCM3 genes are a common cause of familial cerebral cavernous malformations (CCMs). In current molecular genetic laboratories, targeted next-generation sequencing or multiplex ligation-dependent probe amplification are mostly used to identify copy number variants (CNVs). However, both techniques are limited in their ability to specify the breakpoints of CNVs and identify complex structural variants (SVs). To overcome these constraints, we established a targeted Cas9-mediated nanopore sequencing approach for CNV detection with single nucleotide resolution. Using a MinION device, we achieved complete coverage for the CCM genes and determined the exact size of CNVs in positive controls. Long-read sequencing for a CCM1 and CCM2 CNV revealed that the adjacent ANKIB1 and NACAD genes were also partially or completely deleted. In addition, an interchromosomal insertion and an inversion in CCM2 were reliably re-identified by long-read sequencing. The refinement of CNV breakpoints by long-read sequencing enabled fast and inexpensive PCR-based variant confirmation, which is highly desirable to reduce costs in subsequent family analyses. In conclusion, Cas9-mediated nanopore sequencing is a cost-effective and flexible tool for molecular genetic diagnostics which can be easily adapted to various target regions.


  • Open Access

    Hereditary Breast and Ovarian Cancer Service in Sparsely Populated Western Pomerania

    by Ute Felbor, Robin Bülow, Rita K. Schmutzler, Matthias Rath

    The German Consortium Hereditary Breast and Ovarian Cancer (GC-HBOC) consists of 23 academic centers striving to provide high-quality regional care for affected individuals and healthy at-risk family members. According to the standard operating procedures defined by the GC-HBOC, a Familial Breast and Ovarian Cancer Center was implemented at the University Medicine Greifswald over a four-year period from 2018 to 2021, despite the COVID-19 pandemic. Genetic analyses were performed in a total of 658 individuals, including 41 males, which paved the way to local annual risk-adapted breast cancer surveillance for 91 women and prophylactic surgery for 34 women in 2021. Our experience in the North Eastern part of Germany demonstrates that it is possible to establish a high-risk breast and ovarian cancer service even in a sparsely populated region. Major facilitators are the interdisciplinary collaboration of dedicated local experts, the support of the GC-HBOC, fruitful clinical and scientific cooperations and the use of technical improvements. As a blueprint, our project report may help to further expand the network of specialized and knowledge-generating care for HBOC families.


  • Open Access

    Using CRISPR/Cas9 genome editing in human iPSCs for deciphering the pathogenicity of a novel CCM1 transcription start site deletion

    by Robin A. Pilz, Dariush Skowronek, Motaz Hamed, Anja Weise, Elisabeth Mangold, Alexander Radbruch, Torsten Pietsch, Ute Felbor, Matthias Rath

    Cerebral cavernous malformations are clusters of aberrant vessels that can lead to severe neurological complications. Pathogenic loss-of-function variants in the CCM1, CCM2, or CCM3 gene are associated with the autosomal dominant form of the disease. While interpretation of variants in protein-coding regions of the genes is relatively straightforward, functional analyses are often required to evaluate the impact of non-coding variants. Because of multiple alternatively spliced transcripts and different transcription start points, interpretation of variants in the 5′ untranslated and upstream regions of CCM1 is particularly challenging. Here, we identified a novel deletion of the non-coding exon 1 of CCM1 in a proband with multiple CCMs which was initially classified as a variant of unknown clinical significance. Using CRISPR/Cas9 genome editing in human iPSCs, we show that the deletion leads to loss of CCM1 protein and deregulation of KLF2, THBS1, NOS3, and HEY2 expression in iPSC-derived endothelial cells. Based on these results, the variant could be reclassified as likely pathogenic. Taken together, variants in regulatory regions need to be considered in genetic CCM analyses. Our study also demonstrates that modeling variants of unknown clinical significance in an iPSC-based system can help to come to a final diagnosis.


  • Open Access

    Contact-dependent signaling triggers tumor-like proliferation of CCM3 knockout endothelial cells in co-culture with wild-type cells

    by Matthias Rath, Konrad Schwefel, Matteo Malinverno, Dariush Skowronek, Alexandra Leopoldi, Robin A. Pilz, Doreen Biedenweg, Sander Bekeschus, Josef M. Penninger, Elisabetta Dejana, et al.

    Cerebral cavernous malformations (CCM) are low-flow vascular lesions prone to cause severe hemorrhage-associated neurological complications. Pathogenic germline variants in CCM1, CCM2, or CCM3 can be identified in nearly 100% of CCM patients with a positive family history. In line with the concept that tumor-like mechanisms are involved in CCM formation and growth, we here demonstrate an abnormally increased proliferation rate of CCM3-deficient endothelial cells in co-culture with wild-type cells and in mosaic human iPSC-derived vascular organoids. The observation that NSC59984, an anticancer drug, blocked the abnormal proliferation of mutant endothelial cells further supports this intriguing concept. Fluorescence-activated cell sorting and RNA sequencing revealed that co-culture induces upregulation of proangiogenic chemokine genes in wild-type endothelial cells. Furthermore, genes known to be significantly downregulated in CCM3−/− endothelial cell mono-cultures were upregulated back to normal levels in co-culture with wild-type cells. These results support the hypothesis that wild-type ECs facilitate the formation of a niche that promotes abnormal proliferation of mutant ECs. Thus, targeting the cancer-like features of CCMs is a promising new direction for drug development.


  • Open Access

    Improving the Sample-Complexity of Deep Classification Networks with Invariant Integration

    by Matthias Rath, Alexandru Paul Condurache

    Leveraging prior knowledge on intraclass variance due to transformations is a powerful method to improve the sample complexity of deep neural networks. This makes them applicable to practically important use-cases where training data is scarce. Rather than being learned, this knowledge can be embedded by enforcing invariance to those transformations. Invariance can be imposed using group-equivariant convolutions followed by a pooling operation. For rotation-invariance, previous work investigated replacing the spatial pooling operation with invariant integration which explicitly constructs invariant representations. Invariant integration uses monomials which are selected using an iterative approach requiring expensive pre-training. We propose a novel monomial selection algorithm based on pruning methods to allow an application to more complex problems. Additionally, we replace monomials with different functions such as weighted sums, multi-layer perceptrons and self-attention, thereby streamlining the training of invariant-integration-based architectures. We demonstrate the improved sample complexity on the Rotated-MNIST, SVHN and CIFAR-10 datasets where rotation-invariant-integration-based Wide-ResNet architectures using monomials and weighted sums outperform the respective baselines in the limited sample regime. We achieve state-of-the-art results using full data on Rotated-MNIST and SVHN where rotation is a main source of intraclass variation. On STL-10 we outperform a standard and a rotation-equivariant convolutional neural network using pooling.